Buy SAGE Therapeutics Stock | SAGE Stock Price & Latest News | Public.com
SAGE

SAGE Therapeutics

$0.00 (0.00%)Today
    View SAGE Therapeutics (SAGE) stock trends here

    About SAGE

    SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment f...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    18.19
    11.25
    4.31
    -2.63
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$1.90

    Actual EPS
    Q1 2021

    Stats

    Market Cap$4,87B
    Volume602,94k
    Price-to-Earnings Ratio7.53
    Dividend Rate
    Dividend Yield
    1 Year High$98.39
    1 Year Low$25.01
    Open$81.73
    High$83.28
    Low$80.47

    Buy any stock with any amount of money.

    Download the App
    Download the app